Summary: The Centers for Medicare & Medicaid Services modified its Implantable Cardioverter Defibrillators coverage policy, with an effective date of May 15, 2026. Here's what billing teams need to do.
CMS ICD coverage has always been one of the higher-stakes areas in cardiac billing — denials are frequent, documentation requirements are strict, and the financial exposure per claim is significant. This modification to the CMS implantable cardioverter defibrillator coverage policy means your billing team needs to review patient selection criteria, prior authorization workflows, and documentation standards before May 15, 2026. The policy does not list specific CPT or HCPCS codes in the data available for this version — but that doesn't reduce the urgency. ICD billing touches dozens of procedure and diagnosis codes, and any shift in medical necessity criteria ripples across all of them.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS |
| Policy | Implantable Cardioverter Defibrillators (ICDs) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | 2026-05-15 |
| Impact Level | High |
| Specialties Affected | Cardiology, Cardiac Electrophysiology, Cardiac Surgery, Hospital Outpatient, Inpatient Facilities |
| Key Action | Audit ICD patient selection documentation and prior authorization workflows before May 15, 2026 |
CMS Implantable Cardioverter Defibrillator Coverage Criteria and Medical Necessity Requirements 2026
The CMS ICD coverage policy governs when Medicare will pay for implantation of a single-chamber, dual-chamber, or cardiac resynchronization therapy defibrillator (CRT-D). Medical necessity is the central gating factor — and CMS has historically been exacting about it.
Under the existing National Coverage Determination framework, ICD coverage for Medicare beneficiaries depends on the patient's underlying cardiac condition, ejection fraction, functional status, and whether they've received optimal medical therapy for a defined period. These aren't soft criteria. CMS expects documentation that each condition was evaluated and met before the device was implanted.
Because the specific detail of this policy version was not available at time of publication, the criteria described here reflect the established CMS ICD coverage framework. Verify the full text of the May 15, 2026 modification at the official CMS source before updating your clinical documentation templates.
Primary Coverage Indications for CMS ICD Reimbursement
CMS generally covers ICDs under Medicare for patients with a history of sustained ventricular tachyarrhythmia, or for primary prevention in patients with significantly reduced left ventricular ejection fraction (LVEF). The ejection fraction threshold and the required period of optimal medical therapy are the two criteria that generate the most claim denial activity.
For secondary prevention — patients who have already experienced a life-threatening arrhythmia — medical necessity documentation should show the arrhythmia was not caused by a reversible condition. That distinction matters. A defibrillator placed after a transient, correctable cause won't meet coverage criteria under the CMS ICD coverage policy, regardless of the patient's current LVEF.
For primary prevention, the standard CMS framework requires LVEF at or below 35%, documentation of heart failure symptoms, and confirmation that the patient has been on optimal medical therapy. The waiting period after a myocardial infarction or revascularization is a common documentation gap — make sure your pre-authorization checklist captures the exact date of the qualifying event.
Prior Authorization and Shared Decision-Making
CMS has required a shared decision-making conversation with a patient before ICD implantation in certain primary prevention scenarios. This isn't optional, and it needs to be documented in the medical record. Missing shared decision-making documentation is one of the cleaner reasons a claim gets pulled on audit.
If your facility uses a standardized shared decision-making tool, confirm it's CMS-accepted and that the documentation includes the date, the clinician who conducted it, and what decision aids were used. Prior authorization isn't universally required for ICD implantation across all Medicare plans, but Medicare Advantage plans often impose their own prior auth requirements on top of original Medicare criteria. Check each plan individually.
CMS ICD Exclusions and Non-Covered Indications
CMS does not cover ICD implantation in all cardiac patients — and some of the non-covered scenarios are where billing teams get into trouble.
Patients with NYHA Class IV heart failure who are not candidates for cardiac transplant or ventricular assist devices are generally excluded from primary prevention ICD coverage under CMS policy. The rationale is that the expected survival benefit doesn't meet the threshold for coverage. Bill one of these and you're looking at a denial — and potentially a repayment demand if the claim paid on first pass.
ICDs implanted within 40 days of a myocardial infarction or within three months of a coronary artery bypass graft or percutaneous coronary intervention are also excluded for primary prevention indications. These waiting periods exist because LVEF often improves after revascularization, and the medical necessity determination needs to reflect the patient's stable, post-recovery status. If your electrophysiology team is implanting devices close to these windows, tighten your pre-procedure eligibility review process.
Patients with expected survival of less than one year due to non-cardiac conditions also fall outside covered indications. This is a clinical judgment call that must be documented. Vague documentation here invites post-payment audit scrutiny.
Coverage Indications at a Glance
This table reflects the standard CMS ICD coverage framework. Verify against the May 15, 2026 policy text for any modifications to these criteria.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Secondary prevention — survived VT/VF not due to reversible cause | Covered | Not specified in policy data | Document arrhythmia type and ruling out reversible cause |
| Primary prevention — LVEF ≤35%, ischemic cardiomyopathy, NYHA Class II–III, on optimal medical therapy | Covered | Not specified in policy data | Shared decision-making documentation required |
| Primary prevention — LVEF ≤35%, non-ischemic cardiomyopathy, NYHA Class II–III, on optimal medical therapy | Covered | Not specified in policy data | Must document duration of optimal medical therapy |
| NYHA Class IV, not candidate for transplant or LVAD | Not Covered | Not specified in policy data | Expected survival benefit does not meet CMS threshold |
| ICD within 40 days post-MI (primary prevention) | Not Covered | Not specified in policy data | Waiting period required before reassessment |
| ICD within 90 days post-CABG or PCI (primary prevention) | Not Covered | Not specified in policy data | LVEF must be reassessed after recovery period |
| Non-cardiac terminal condition with survival < 1 year | Not Covered | Not specified in policy data | Clinical documentation of prognosis required |
| CRT-D for LBBB, QRS ≥150ms, LVEF ≤35%, NYHA Class II–IV | Covered | Not specified in policy data | Verify QRS duration and bundle branch morphology documented |
Note: The policy data for this version does not include specific CPT, HCPCS, or ICD-10 codes. Do not assume code applicability without reviewing the full policy text.
CMS ICD Billing Guidelines and Action Items 2026
ICD billing is high-dollar, high-scrutiny territory. A single missed documentation element can flip a five-figure payment into a denial or a recoupment. Here's what to do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull your ICD claims from the last 12 months and audit them against current coverage criteria. Look specifically for shared decision-making documentation, LVEF values with dates, and optimal medical therapy start dates. If you're missing any of these on paid claims, that's your audit exposure. |
| 2 | Update your pre-procedure checklist to capture the full set of CMS medical necessity criteria before the device is implanted. Don't leave documentation to the operative note. The checklist should flag the waiting period windows — 40 days post-MI, 90 days post-revascularization — and block scheduling if the patient is inside those windows. |
| 3 | Review your prior authorization workflow for Medicare Advantage plans. Original Medicare doesn't always require prior auth for ICD implantation, but most MA plans do. Map out which plans require it, what documentation they need, and what the turnaround time is. A missing prior auth on an MA ICD claim is a clean denial with no recourse. |
| 4 | Confirm your shared decision-making documentation meets CMS standards. If your current template doesn't capture the date, clinician, and decision aid used, fix it before May 15, 2026. This is an audit magnet. |
| 5 | Train your cardiology coders on the distinction between primary and secondary prevention indications. These map to different clinical scenarios and different documentation requirements. A coder who doesn't know the difference between a primary prevention ICD and a secondary prevention ICD will miscapture diagnosis codes and set up the claim for denial. |
| 6 | If your volume of ICD cases is significant — more than 20 per month — loop in your compliance officer before the effective date. A modified coverage policy is the right moment to do a prospective audit, not a reactive one. Your compliance officer can help you structure a targeted review that won't disrupt your revenue cycle. |
| 7 | Watch for any MAC-specific guidance tied to this modification. Medicare Administrative Contractors sometimes issue Local Coverage Determinations that layer additional requirements on top of the national policy. Check your MAC's website for any related LCD updates after May 15, 2026. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Implantable Cardioverter Defibrillators Under This Policy
The policy data for this version of the CMS ICD coverage policy does not include specific CPT, HCPCS, or ICD-10 codes. Do not use this post as a code reference for charge capture. Pull codes directly from the full policy text at the official CMS source.
That said, ICD billing typically involves a cluster of procedure codes covering device implantation, pulse generator replacement, lead placement, and related services. It also involves a set of ICD-10-CM diagnosis codes that must support the specific covered indication — whether that's a documented arrhythmia history for secondary prevention or the combination of reduced ejection fraction and heart failure class for primary prevention.
Your coding team should cross-reference the updated policy text against your current charge capture templates to confirm every code in your set still maps to a covered indication under the May 2026 modification. If CMS narrowed any criteria or added any exclusions, some codes you're currently billing may need updated documentation requirements attached to them.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.